Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Semaglutide is a Glucagon-like Peptide-1 (GLP-1) receptor agonist prescribed for weight management and Type 2 Diabetes treatment
#GLP1 #Microbiome #Obesity #Type2Diabetes #MetabolicHealth #PrecisionMedicine #SystemsBiology #TranslationalMedicine #GutBrainAxis #Endocrinology #Immunometabolism #MultiOmics #PersonalizedMedicine #LifeSciences #BiomedicalResearch Related reading (Open Access): GLP-1 Therapy Through a Microbiome Lens GLP-1 Therapy and the Gut Microbiome Connection Is the Gut Microbiome the Missing Mediator of GLP-1 Therapy
Finally, the cohort was limited to those in which beginning of combination therapy was between January 1 st 2007 and Dec 31 st 2018
Read: Catalent x Novo: the GLP-1 wars heat up What are GLP-1 agonists
US$ 28.72
US$ 22.20
US$ 23.67
US$ 22.94
